Cancer treatment could face landmark moment with promising vaccine
The drug, intismeran autogene, treats melanoma, the deadliest form of skin cancer, of which the US National Cancer…
2 Healthcare Stocks That Could Soar Over the Next 5 Years
While the stock market is facing significant volatility right now, there is a decent chance it will still…
FDA plans bonuses to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA drug approvals: Makary and Prasad say one study will be enough
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
Moderna mRNA-based drug cut the risk of recurrence or death when combined with immunotherapy Keytruda
“Today’s results highlight the potential of a prolonged benefit of the intismeran autogene and Keytruda combination,” Kyle Holen,…
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
Moderna could tumble once again, if there’s a lack of positive news in its upcoming earnings release. Novo…